In places like Australia, where metropolitan areas are separated by an entire continent, donor hearts used to go unused simply because transplant teams couldn't get the organ to a recipient in time.

A new medical technology expected to be on the market in 2027 is poised to help patients in middle America have greater access to heart transplants. Xvivo Perfusion, a leader in organ transplant ...

The US Food and Drug Administration (FDA) has conditionally approved TransMedics Group’s investigational device exemption (IDE) to commence the next-generation OCS ENHANCE Heart study. Part A of the ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. TransMedics Group (NasdaqGM:TMDX) received full FDA approval for its ...

Please provide your email address to receive an email when new articles are posted on . Most respondents reported they would undergo a donation procedure that maximized use of their organs. Many ...

Perfusion describes when fluids such as blood and lymph pass through tissue. A perfusionist is a professional who operates machinery when this process requires assistance, such as during heart surgery ...